Clinical Trial Update: Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial of VC005 tablets in adults with moderate-to-severe atopic dermatitis has completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• VC005

Snippet

Sponsor: Jiangsu vcare pharmaceutical technology co., LTD | Conditions: Moderate to Severe Atopic Dermatitis | Phase 2 | Status: COMPLETED